Works matching IS 15228517 AND DT 2022 AND VI 24 AND IP 12
Results: 20
Corrigendum to: Influence of county-level geographic/ancestral origin on glioma incidence and outcomes in US Hispanics.
- Published in:
- 2022
- Publication type:
- Correction Notice
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2222, doi. 10.1093/neuonc/noac240
- Publication type:
- Article
EGFR, the Lazarus target for precision oncology in glioblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2035, doi. 10.1093/neuonc/noac204
- By:
- Publication type:
- Article
EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2015, doi. 10.1093/neuonc/noac188
- By:
- Publication type:
- Article
EV packing allows meningioma tracking in blood.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2091, doi. 10.1093/neuonc/noac230
- By:
- Publication type:
- Article
promising preclinical model for TERT promoter mutation in glioblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2076, doi. 10.1093/neuonc/noac167
- By:
- Publication type:
- Article
HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant glioma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2121, doi. 10.1093/neuonc/noac111
- By:
- Publication type:
- Article
Does increase of symptoms mean progression?
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2170, doi. 10.1093/neuonc/noac218
- By:
- Publication type:
- Article
FRK inhibits glioblastoma progression via phosphorylating YAP and inducing its ubiquitylation and degradation by Siah1.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2107, doi. 10.1093/neuonc/noac156
- By:
- Publication type:
- Article
Comparative single-cell RNA-sequencing profiling of BMP4-treated primary glioma cultures reveals therapeutic markers.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2133, doi. 10.1093/neuonc/noac143
- By:
- Publication type:
- Article
comprehensive profiling of the immune microenvironment of breast cancer brain metastases.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2146, doi. 10.1093/neuonc/noac136
- By:
- Publication type:
- Article
Diagnostic potential of extracellular vesicles in meningioma patients.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2078, doi. 10.1093/neuonc/noac127
- By:
- Publication type:
- Article
Long-term outcomes and late toxicity of adult medulloblastoma treated with combined modality therapy: A contemporary single-institution experience.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2180, doi. 10.1093/neuonc/noac126
- By:
- Publication type:
- Article
Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2172, doi. 10.1093/neuonc/noac125
- By:
- Publication type:
- Article
Characteristics of children ≤36 months of age with DIPG: A report from the international DIPG registry.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2190, doi. 10.1093/neuonc/noac123
- By:
- Publication type:
- Article
Limited surgery and conformal photon radiation therapy for pediatric craniopharyngioma: long-term results from the RT1 protocol.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2200, doi. 10.1093/neuonc/noac124
- By:
- Publication type:
- Article
Endocrine outcomes after limited surgery and conformal photon radiation therapy for pediatric craniopharyngioma: Long-term results from the RT1 protocol.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2210, doi. 10.1093/neuonc/noac115
- By:
- Publication type:
- Article
Decitabine increases neoantigen and cancer testis antigen expression to enhance T-cell–mediated toxicity against glioblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2093, doi. 10.1093/neuonc/noac107
- By:
- Publication type:
- Article
Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2159, doi. 10.1093/neuonc/noac097
- By:
- Publication type:
- Article
TERT promoter C228T mutation in neural progenitors confers growth advantage following telomere shortening in vivo.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2063, doi. 10.1093/neuonc/noac080
- By:
- Publication type:
- Article